The cancer IVD market is accelerating as early detection becomes a global priority, fueled by rising cancer rates, technological advancements, and expanding access to precision diagnostics. With a projected CAGR of 6.04% through 2034, the market is driven by growing awareness, AI integration, and robust investment in healthcare infrastructure.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cancer IVD Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cancer IVD Market, by Product and Service
8.1.1 Reagents and Kits
8.1.1.1. Market Revenue and Forecast
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast
8.1.3. Data Management Software
8.1.3.1. Market Revenue and Forecast
8.1.4. Services
8.1.4.1. Market Revenue and Forecast
9.1. Cancer IVD Market, by Technology
9.1.1. Clinical Chemistry
9.1.1.1. Market Revenue and Forecast
9.1.2. Immunochemistry/Immunoassays
9.1.2.1. Market Revenue and Forecast
9.1.3. Hematology
9.1.3.1. Market Revenue and Forecast
9.1.4. Coagulation
9.1.4.1. Market Revenue and Forecast
9.1.5. Hemostasis
9.1.5.1. Market Revenue and Forecast
9.1.6. Microbiology
9.1.6.1. Market Revenue and Forecast
9.1.7. Molecular Diagnostics
9.1.7.1. Market Revenue and Forecast
9.1.8. Others
9.1.8.1. Market Revenue and Forecast
10.1. Cancer IVD Market, by End-users
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast
10.1.2. Laboratories
10.1.2.1. Market Revenue and Forecast
10.1.3. Academics
10.1.3.1. Market Revenue and Forecast
10.1.4. Point-of-care Testing
10.1.4.1. Market Revenue and Forecast
10.1.5. Patient Self-testing
10.1.5.1. Market Revenue and Forecast
10.1.6. Others
10.1.6.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product and Service
11.1.2. Market Revenue and Forecast, by Technology
11.1.3. Market Revenue and Forecast, by End-users
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product and Service
11.1.4.2. Market Revenue and Forecast, by Technology
11.1.4.3. Market Revenue and Forecast, by End-users
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product and Service
11.1.5.2. Market Revenue and Forecast, by Technology
11.1.5.3. Market Revenue and Forecast, by End-users
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product and Service
11.2.2. Market Revenue and Forecast, by Technology
11.2.3. Market Revenue and Forecast, by End-users
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product and Service
11.2.4.2. Market Revenue and Forecast, by Technology
11.2.4.3. Market Revenue and Forecast, by End-users
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product and Service
11.2.5.2. Market Revenue and Forecast, by Technology
11.2.5.3. Market Revenue and Forecast, by End-users
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product and Service
11.2.6.2. Market Revenue and Forecast, by Technology
11.2.6.3. Market Revenue and Forecast, by End-users
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product and Service
11.2.7.2. Market Revenue and Forecast, by Technology
11.2.7.3. Market Revenue and Forecast, by End-users
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product and Service
11.3.2. Market Revenue and Forecast, by Technology
11.3.3. Market Revenue and Forecast, by End-users
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product and Service
11.3.4.2. Market Revenue and Forecast, by Technology
11.3.4.3. Market Revenue and Forecast, by End-users
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product and Service
11.3.5.2. Market Revenue and Forecast, by Technology
11.3.5.3. Market Revenue and Forecast, by End-users
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product and Service
11.3.6.2. Market Revenue and Forecast, by Technology
11.3.6.3. Market Revenue and Forecast, by End-users
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product and Service
11.3.7.2. Market Revenue and Forecast, by Technology
11.3.7.3. Market Revenue and Forecast, by End-users
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product and Service
11.4.2. Market Revenue and Forecast, by Technology
11.4.3. Market Revenue and Forecast, by End-users
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product and Service
11.4.4.2. Market Revenue and Forecast, by Technology
11.4.4.3. Market Revenue and Forecast, by End-users
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product and Service
11.4.5.2. Market Revenue and Forecast, by Technology
11.4.5.3. Market Revenue and Forecast, by End-users
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product and Service
11.4.6.2. Market Revenue and Forecast, by Technology
11.4.6.3. Market Revenue and Forecast, by End-users
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product and Service
11.4.7.2. Market Revenue and Forecast, by Technology
11.4.7.3. Market Revenue and Forecast, by End-users
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product and Service
11.5.2. Market Revenue and Forecast, by Technology
11.5.3. Market Revenue and Forecast, by End-users
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product and Service
11.5.4.2. Market Revenue and Forecast, by Technology
11.5.4.3. Market Revenue and Forecast, by End-users
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product and Service
11.5.5.2. Market Revenue and Forecast, by Technology
11.5.5.3. Market Revenue and Forecast, by End-users
12.1. Abbott
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. BioMérieux SA
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. QuidelOrtho Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Siemens Healthineers AG
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bio-Rad Laboratories, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Qiagen
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Sysmex Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Charles River Laboratories
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Quest Diagnostics Incorporated
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Agilent Technologies, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description